First Rounder: Jeremy Levin

Jeremy Levin is chairman and CEO of Ovid Therapeutics, formerly president and CEO of Teva Pharmaceutical Industries, and former member of the executive committee at Bristol-Myers Squibb, where he led that company's 'string of pearls' strategy. His conversation with Nature Biotechnology covers shifting his mindset from treating patients to business development, his youth in South Africa, and how his past influences his view of the 2016 US presidential election results. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Dec 20, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

First Rounder: Jeremy Levin

0:00 1:35:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of First Rounders?

This episode is 1 hour and 35 minutes long.

When was this First Rounders episode published?

This episode was published on December 20, 2016.

Can I download this First Rounders episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!